ACCD Kacepetan wutah bathi saben saham ing taun lumaku Accolade

Simbol resmi perusahaan Accolade (ACCD)

The expansion of corporate subscriptions for personalized healthcare navigation is yielding tangible results, as evidenced by the year-over-year change in earnings per share for Accolade (ACCD). The value -57.70 reflects the latest level of this metric. The cloud-based SaaS service enables seamless scaling of benefits management, while long-term B2B contracts with large enterprises provide a robust defensive moat amid fierce competition in the telemedicine sector.

ACCD: Wutah bathi ing taun lumaku Accolade, Inc. 04.07.2022 - 19.04.2025

Rincian metrik keuangan lan pasar accolade.com (ACCD)

- rega lan prakiraan konsensus rega:
Kutipan saham Accolade, Inc.|ACCD - Bagan rega target
- data kapitalisasi pasar:
Nilai pasar ACCD|ACCD - Nilai Total Perusahaan
- data ekuitas miturut neraca:
Aset Bersih saben Siji Saham Accolade|ACCD - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku accolade.com|ACCD - Total Aset Perusahaan
- rincian utang lan likuiditas:
Rasio Utang marang Ekuitas Accolade|ACCD - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal Accolade, Inc.|ACCD - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku ACCD|ACCD - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Accolade|Indikator likuiditas cepet accolade.com
- informasi bathi lan kelipatan valuasi:
ACCD - Bathi resik|Prakiraan bathi resik Accolade|ACCD - Koefisien rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep Accolade, Inc.|ACCD - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan ACCD|ACCD - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Accolade|ACCD - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan accolade.com|ACCD - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Accolade
Pambiji fundamental:Accolade
Produk merek Accolade

Accolade (ACCD) management's operational discipline in optimizing its telemedicine platform is driving a steady reduction in losses. By analyzing annual EPS progress, investors can track the trend of earnings per share relative to the previous year, which offsets quarterly reporting lags. The growth of this indicator confirms recovering margins, signaling the business's transition toward a sustainable value generation model.

Pesaing langsung

Wutah bathi resik saben saham ing taun iki Hims & Hers Health, Inc.|Wutah bathi saben saham ing taun lumaku Hinge Health Corp|Kacepetan wutah bathi saben saham ing taun lumaku Teladoc Corp TDOC|Wutah bathi saben saham ing taun lumaku Talkspace, Inc. (TALK)|Wutah bathi saben saham ing taun lumaku LFMD (lifemd.com)|Wutah bathi ing taun lumaku AMWL (Amwell)|Wutah bathi ing taun lumaku Mangoceuticals Inc. MGRX|DarioHealth Corporation - Wutah bathi ing taun lumaku|VSEE (VSee Health, Inc.) - Wutah bathi saben saham ing taun iki|MNDR: Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku biotricity.com (BTCY)|LYT (Lytus Technologies Holdings) - Wutah bathi ing taun lumaku|Wutah bathi ing taun lumaku Ontrak Inc|Wutah bathi ing taun lumaku SHLT|Wutah bathi resik saben saham ing taun iki Thorne Research THRN